Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Identification, optimization and use of cryptic HLA-A24 epitopes for immunotherapy

Identification, optimization and use of cryptic HLA-A24 epitopes for immunotherapy

US Patent 8900600 · Granted Dec 2, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of a vaccine targeting a cryptic tert epitope, for treating cancer in a HLA-2024
Use of a vaccine targeting a cryptic tert epitope, for treating cancer in a HLA-2024
Identification, optimization and use of shared HLA-B*0702 epitopes for immunothe2018
Identification, optimization and use of shared HLA-B*0702 epitopes for immunothe2018
Use of native peptides and their optimized derivatives for vaccination2014
Identification, optimization and use of cryptic HLA-B7 epitopes for immunotherap2013
Identification, optimization and use of cryptic HLA-B7 epitopes for immunotherap2013
Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereo2011
Immunogenic polypeptide composed of tumor antigen-derived optimized cryptic pept2011